nafamostat has been researched along with Brain Infarction in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Brain Infarction: Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "NM treatment attenuated the brain infarct volume and the loss of body weight and improved the recovery of sensorimotor and cognitive functions." | 5.46 | Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats. ( Fang, Y; Li, C; Liao, H; Liu, Y; Sun, H; Tao, X; Wang, J; Zhou, XF, 2017) |
| "NM treatment attenuated the brain infarct volume and the loss of body weight and improved the recovery of sensorimotor and cognitive functions." | 1.46 | Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats. ( Fang, Y; Li, C; Liao, H; Liu, Y; Sun, H; Tao, X; Wang, J; Zhou, XF, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Li, C | 1 |
| Wang, J | 1 |
| Fang, Y | 1 |
| Sun, H | 1 |
| Tao, X | 1 |
| Zhou, XF | 1 |
| Liao, H | 1 |
1 other study available for nafamostat and Brain Infarction
| Article | Year |
|---|---|
Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats.
Topics: Animals; Axons; Benzamidines; Body Weight; Brain Infarction; Cognition; Cyclic AMP Response Element- | 2017 |